In 2025, outpatient care and hospitalizations for pancreatitis have notably increased in Vale do Paraíba, Brazil, with a jump of 41% and 14.5% respectively compared to the previous year.
In 2025, the Vale do Paraíba region in Brazil has seen a significant rise in both outpatient care and hospitalizations due to pancreatitis, as reported by G1 news outlet. According to data from the State Department of Health, outpatient visits surged by 41%, while hospital admissions increased by 14.5% when compared to 2024. The statistics reflect a concerning trend for a condition that affects the digestive system, suggesting a potential public health issue in the area.
Specifically, the numbers indicate a rise from 39 outpatient care instances and 475 hospitalizations in 2024 to 55 outpatient visits and 544 hospital admissions in 2025. This evaluating data is sourced from the regional health department that oversees 39 municipalities, including major cities like São José dos Campos, Taubaté, and Jacareí. This alarming increase necessitates further scrutiny and investigation into potential causes.
While the State Department of Health has clarified that the rise in pancreatitis cases is not linked to the use of weight loss pens, experts like endocrinologist Raquel Donadel Kroth suggest a possible correlation with the growing interest in these medications. This statement might fuel ongoing discussions around the consequences of pharmaceutical interventions for weight loss, emphasizing the need for a dialogue regarding health education and prevention strategies in the region.
